Quinone oxidoreductase-2-mediated prodrug cancer therapy

Mark R. Middleton, Richard Knox, Emma Cattell, Udo Oppermann, Rachel Midgley, Raghib Ali, Tim Auton, Roshan Agarwal, David Anderson, Debashis Sarker, Ian Judson, Tsuyoshi Osawa, Victoria J. Spanswick, Scot Davies, John A. Hartley, David J. Kerr

Research output: Contribution to journalArticlepeer-review


Dive into the research topics of 'Quinone oxidoreductase-2-mediated prodrug cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences